Effect of Ethiopian multiflora honey on fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients

International Journal of STD and AIDS

Volumn 21, Issue 11, 2010, Pages 741-745

  Mulu, A ^a   Diro, E ^a   Tekleselassie, H ^b   Belyhun, Y ^a   Anagaw, B ^a   Alemayehu, M ^a   Gelaw, A ^a   Biadglegne, F ^a   Desalegn, K ^a   Yifiru, S ^a   Tiruneh, M ^a   Kassu, A ^a   Nishikawa, T ^c   Isogai, E ^d  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c HOKKAIDO UNIVERSITY OF EDUCATION   (Japan)

^d HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Antifungal effect; Candidiasis; HIV AIDS; Honey

Indexed keywords

FLUCONAZOLE; MOUTHWASH;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGAR DILUTION; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FUNGICIDAL ACTIVITY; HONEY; HUMAN; MOUTH CAVITY; MOUTH LESION; PRIORITY JOURNAL; TRADITIONAL MEDICINE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, FUNGAL; ETHIOPIA; FLUCONAZOLE; HONEY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH; NEPHELOMETRY AND TURBIDIMETRY;

EID: 78650833477     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010140     Document Type: Article

References (39)

1. United Nation Program on HIV-1/AIDS. UNAIDS/WHO. AIDS epidemic update. World Health Organization, Geneva, 2008
2. Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:415-21
3. Brawner DL, Hovan AJ. Oral candidiasis in HIV-infected patients. Curr Top med Mycol 1995;6:113-25
4. Dupont B, Denning DW, Marriott D, et al. Mycosis and AIDS patients. J Med Vet Mycol 1994;32:65-77
5. Glick M, Muzyka BC, Lurie D, et al. Oral manifestations associated with HIV-related disease as markers for immunesuppression and AIDS. Oral Surg oral Med oral Pathol 1994;77:344-9
6. Gugani HC, Becker K, Fegeler W, et al. Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses 2003;46:299-306
7. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511
8. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995;8:462-78
9. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990's. Eur J Clin Microbiol Infect Dis 1992;11:287-91
10. Woldeamanuel Y, Abate D. Characterization of C. albicans isolates from the oral cavity of HIV positive patients. Ethiop Med J 1998;36:235-43
11. Arribas JR, Hernadez-Albujar S, Gonzalez-Garcia JJ, et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 2000;14:979-85
12. Eyeson JD, Tenant-Flowers M, Cooper DJ, et al. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. J Oral Pathol Med 2002;31:169-74
13. Ongsiriwet S, Iamaroon A, Sriburee P, et al. Oral colonization of Candida species in perinatally HIV-infected children in Northern Thailand. J Oral Sci 2004;46:101-5
14. World Health Organization. Drug Information Bulletin 1999;13:230
15. World Health Organization. WHO Traditional Medicine Strategy, 2002-2005. WHO/EDM/TRM/2002.1
16. Tovey FI. Honey and healing. J R Soc Med 1991;82:447-8
17. Zumla A, Lulat A. Honey - a remedy rediscovered. J R Soc Med 1989;82:384-5
18. Root A, Root ER. ABC and XYZ of bee culture. An Encyclopedia Pertaining of Specific and Practical Culture of Bee. Medina: The AI Root Company, 1947
19. Molan PC. The antibacterial activity of honey. 1. The nature of antibacterial activity. Bee World 1992;73:5-28
20. Mulu A, Tessema B, Derbie F. In vitro assessment of the antimicrobial potential of honey on some common human pathogens. Ethiop J Health Dev 2004;18:107-11
21. Mulu A, Tessema B, Kassu A. Antibacterial activity of Honey produced by Honeybees (Apis Mellifera) on bacterial species isolated from wound Infection, Gondar University Teaching Hopsital, Northwest Ethiopia. Ethiop Pharm J 2006;5:23-6
22. Beighton D, Ludford R, Clark DT, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 1995;33:3025-37
23. Isogai H, Mulu A, Diro E, et al. Identification of Candida species from human immunodeficiency virus-infected patients in Ethiopia by combination of CHROMagar, Tobacco agar and PCR of amplified internally transcribed rRNA spacer region. J Appl Res 2010;10:1-8
24. Woods G, Washington JA. Antimicrobial susceptibility test; dilution and disk diffusion methods. In: Murray PR (ed). Manual of Clinical Microbiology. 6th edn. Herndon: ASM Press, 1995:1327-32
25. Margaret FP, Mark TL, Layne OG. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-Year Period. Antimicrob Agents Chemother 1994;38:1422-4
26. Anaissie E, Paetznick V, Bodey GP. Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob Agents Chemother 1991;35:1641-6
27. National Committee for Clinical Laboratory Standards, M27-A2. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard Second Edition 2002;22(15)
28. Calderone RA. Candida and Candidiasis. Washington, DC: ASM Press, 2002
29. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001;9:327-35
30. Irish J, Carter DA, Sholohi T, et al. Honey has an antifungal effect against Candida species. Med Mycol 2006;44:289-91
31. Koc AN, Silici S, Ercal BD, et al. Antifungal activity of Turkish honey against Candida spp. and Trichosporon spp.: an in vitro evaluation.Med Mycol 2008;2:1-6
32. Mizahi A, Doron R. Antimicrobial effects of hive products. Israel J Med Sci 1982;5:23-37
33. Boukraa L, Benbarek H, Moussa A. Synergistic action of starch and honey against Candida albicans in correlation with diastase number. Braz J Microbiol 2008;39:40-3
34. White TC, Hollemann S, Dy F, et al. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002;46:1704-13
35. Jabra Rizk MA, Falker WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004;10:14-9
36. Bogdanv S. Characterization of the antibacterial substances in honey. Am Bee J 1984;17:74-6
37. Andrew B. More common opportunistic infections; their symptoms, diagnosis, prophylaxis and treatment Positive. Mag issue 2003;42:1-10
38. Enwuru CA, Ogunledun A, Idika N, et al. Fluconazole resistant opportunistic oro-pharyngeal candida and non-candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci 2008;8:142-48
39. Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999;33:217-22